Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CTI BIOPHARMA CORP (CTI)

Income Statement Business | Product | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Total revenues  21.118.212.32.30.00.00.00.0
Cost of goods sold  1.21.20.90.30.00.00.00.0
Gross profit  19.917.111.42.00.00.00.00.0
            Gross margin  94.5%93.7%92.6%87.9%    
Selling, general and administrative   [+]23.721.521.618.024.713.710.27.6
Research and development  11.98.28.78.010.79.79.39.4
Other operating expenses  -2.1-0.4 11.0    
EBITDA   [+]-13.1-11.7-18.3-34.8-35.2-23.2-19.4-16.9
            EBITDA margin  -62.0%-64.1%-148.5%-1515.6%    
Depreciation and amortization  0.50.50.60.30.10.10.10.1
EBIT   [+]-13.6-12.2-18.9-35.1-35.4-23.4-19.5-17.1
            EBIT margin  -64.5%-67.0%-153.2%-1529.4%    
Interest expense  3.83.63.82.11.40.70.20.2
Other income (expense), net   [+]-0.10.10.00.00.0-0.10.00.0
Pre-tax income  -17.5-15.7-22.7-37.2-36.8-24.2-19.7-17.3
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -17.5-15.7-22.7-37.2-36.8-24.2-19.7-17.3
            Net margin  -82.8%-86.1%-183.7%-1619.8%    
   
Basic EPS   [+]($0.15)($0.13)($0.21)($0.37)($0.41)($0.26)($0.21)($0.23)
Diluted EPS   [+]($0.15)($0.13)($0.21)($0.37)($0.41)($0.26)($0.21)($0.23)
   
Shares outstanding (basic)   [+]114.7121.6108.599.890.193.892.376.4
Shares outstanding (diluted)   [+]114.7121.6108.599.890.193.892.376.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy